Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EZETIMIBE\SIMVASTATIN Cause Transient ischaemic attack? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Transient ischaemic attack have been filed in association with EZETIMIBE\SIMVASTATIN. This represents 0.5% of all adverse event reports for EZETIMIBE\SIMVASTATIN.

9
Reports of Transient ischaemic attack with EZETIMIBE\SIMVASTATIN
0.5%
of all EZETIMIBE\SIMVASTATIN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Transient ischaemic attack From EZETIMIBE\SIMVASTATIN?

Of the 9 reports, 2 (22.2%) required hospitalization.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\SIMVASTATIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does EZETIMIBE\SIMVASTATIN Cause?

Myalgia (244) Acute kidney injury (132) Rhabdomyolysis (113) Drug hypersensitivity (112) Arthralgia (89) Diarrhoea (71) Muscle spasms (70) No adverse event (68) Fatigue (66) Rash (54)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which EZETIMIBE\SIMVASTATIN Alternatives Have Lower Transient ischaemic attack Risk?

EZETIMIBE\SIMVASTATIN vs EZOGABINE EZETIMIBE\SIMVASTATIN vs FACTOR XIII CONCENTRATE EZETIMIBE\SIMVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI EZETIMIBE\SIMVASTATIN vs FAMCICLOVIR EZETIMIBE\SIMVASTATIN vs FAMOTIDINE

Related Pages

EZETIMIBE\SIMVASTATIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack EZETIMIBE\SIMVASTATIN Demographics